Diethelm A G, Deierhoi M H, Hudson S L, Laskow D A, Julian B A, Gaston R S, Bynon J S, Curtis J J
Department of Surgery, University of Alabama School of Medicine, Birmingham, USA.
Ann Surg. 1995 May;221(5):446-57; discussion 457-8. doi: 10.1097/00000658-199505000-00002.
The study analyzed 3359 consecutive renal transplant operations for patient and graft survival, including living related, cadaveric, and living unrelated patients. The analysis was separated into three groups according to immunosuppression and date of transplant.
Improvements in renal transplantation in the past 25 years have been the result of better immunosuppression, organ preservation, and patient selection.
A single transplant center's experience over a 25-year period was analyzed regarding patient and graft survival. Potential risk factors included patient demographics, tissue typing, donor characteristics, number of transplants, acute and chronic rejection, acute tubular necrosis, primary disease, and malignancy.
The primary cause of graft loss was rejection. Improvement in cadaveric graft survival since 1987 with quadruple therapy was not apparent in living donor patients. Race continued to be a negative factor in graft survival. Avoiding previous mismatched antigens and the use of flow cytometry improved allograft survival. The leading cause of death in the past 7 years in cadaveric recipients was cardiac (52%).
Improved graft survival in the past 25 years was related to 1) advances in immunosuppression, 2) better methods of cytotoxic antibody detection, and 3) human lymphocyte antigen match.
本研究分析了连续3359例肾移植手术患者的存活情况及移植物存活情况,包括亲属活体供肾、尸体供肾和非亲属活体供肾患者。根据免疫抑制情况和移植日期将分析分为三组。
过去25年肾移植的改善得益于更好的免疫抑制、器官保存和患者选择。
分析了一个移植中心25年间患者和移植物存活情况的经验。潜在风险因素包括患者人口统计学特征、组织配型、供体特征、移植次数、急慢性排斥反应、急性肾小管坏死、原发疾病和恶性肿瘤。
移植物丢失的主要原因是排斥反应。自1987年以来,四联疗法在尸体供肾患者中未明显改善移植物存活情况。种族仍然是移植物存活的负面因素。避免既往不匹配抗原并使用流式细胞术可提高同种异体移植物存活。过去7年尸体供肾受者的主要死亡原因是心脏疾病(52%)。
过去25年移植物存活情况的改善与以下因素有关:1)免疫抑制的进展;2)更好的细胞毒性抗体检测方法;3)人类淋巴细胞抗原匹配。